跳至主要内容
临床试验/NCT03154801
NCT03154801Unknown不适用

Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2017年7月26日最近更新:
适应症

试验速览

阶段
不适用
入组人数
54
试验地点
2
主要终点
Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire)

研究概览

简要总结

This study aim to ensure that the implementation of a paramedical screening program and counseling in sexual health of patients with neurological pathologies (low-grade gliomas and Multiple Sclerosis) improves their sexual health.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any major patient, followed in the GHPSCF (Groupe Hospitalier Pitié-Salpêtrière Charles Foix) neurology department 2 for a diagnosis of low grade glioma or anaplastic glioma with loss 1p / 19q sub-reserve histo-molecular confirmation after national reading (POLA) and presenting:
  • An MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire) questionnaire with at least one of the items rated "4" or "5" and
  • A HAD (Hospital Anxiety and Depression) questionnaire (depression component) with a score ≤ 11
  • Any major patient with MS(Multiple Sclerosis), followed in the GHPSCF Department of Neurology:
  • With an EDSS (Expanded Disability Status Scale) greater than or equal to 1 and
  • An MSISQ15 questionnaire with at least one of the items rated "4" or "5".
  • A HAD questionnaire (depression component) with a score ≤ 11
  • Signature of informed consent
  • Patient affiliated to a social security system

排除标准

  • Minor patients
  • Pregnant women
  • Patients who do not understand and / or speak French and / or are unable to sign consent
  • Patients with neurological impairment
  • Patients with chronic sexual disorders who have already received treatment.
  • Patients with a HAD score (depression component) greater than 11
  • Patients with MS who had a corticosteroid-treated outbreak in the last two months.
  • Patients with low-grade glioma with clinical and / or radiological scalability during the last three months
  • Any patient whose alteration of the general state would not allow to follow the program.
  • Patients under legal protection
  • For patient's partners:
  • Inclusion criteria:
  • Any patient partner, whose patient has wished to participate and who has accepted.
  • Signing of informed consent
  • Non-Inclusion Criteria:
  • Minor partners
  • Pregnant women
  • Any person who does not understand and / or speak French and / or is unable to sign the consent
  • Partners under legal protection

结局指标

主要结局

Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire)

时间窗: Inclusion and 3 months

Change of MSISQ15 sexual dysfunctional items at 3-months from baseline

次要结局

  • Program satisfaction scale(6 months)
  • Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire)(Inclusion and 6-months)
  • Change of HAD scale (Hospital Anxiety and Depression)(Inclusion and 6 months)
  • Change of Rosenberg's Self-esteem Scale(Inclusion and 6 months)
  • Change of QLQ-C30/BM20 scale (Quality of Life Questionnaire - Core Questionnaire / Brain Module)(Inclusion and 6 months)
  • Change of Quality of life scale(Inclusion and 6 months)
  • Change of SEP59 scale (Sclérose En Plaques)(Inclusion and 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验